Back to APREView full pipeline
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
0 competitors in MDS
View Full LandscapeDrug Information
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
Pegylated Liposomal Doxorubicin Hydrochloride (PLD)Phase 2
High-grade Serous Ovarian Cancer
APR-246Phase 2
Acute Myeloid Leukemia or Myelodysplastic Syndromes
ATRN-119Phase 2
Advanced Solid Tumor
Carboplatin and Pegylated Liposomal Doxorubicin Hydrochloride (PLD)Phase 2
Platinum Sensitive Recurrent High-grade Serous Ovarian Cancer With Mutated p53
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts